Rare and Orphan Diseases

1-10 of 10

• 

  RestartResume

  Expanding Treatment Options in PNH: Expert Approaches to Personalized Care

  Medical Industry Feature

  Expanding Treatment Options in PNH: Expert Approaches to Personalized Care

  • 

    

    Caroline Piatek, MD

    Peer

  • 

    

    Bhumika Patel, MD

    Peer

• 

  RestartResume

  Long-Term PNH Management: Addressing Treatment Goals Beyond Symptom Control

  Medical Industry Feature

  Long-Term PNH Management: Addressing Treatment Goals Beyond Symptom Control

  • 

    

    Arati Chand, MD

    Peer

  • 

    

    Bhumika Patel, MD

    Peer

• 

  RestartResume

  Understanding the Mechanism Behind a Treatment Approach in Indolent Systemic Mastocytosis (ISM)

  Medical Industry Feature

  Understanding the Mechanism Behind a Treatment Approach in Indolent Systemic Mastocytosis (ISM)

• 

  RestartResume

  Challenging Cases in IgA Nephropathy and Identifying Patients for Specialized Care

  Medical Industry Feature

  Challenging Cases in IgA Nephropathy and Identifying Patients for Specialized Care

  • 

    

    Jaimini Patel, PharmD, BCCCP

    Peer

  • 

    

    Sayna Norouzi, MD

    Peer

• 

  RestartResume

  Navigating IgA Nephropathy: Pathogenesis, The Role Of APRIL & The 4-Hit Process, & A Patient Case Study

  Medical Industry Feature

  Navigating IgA Nephropathy: Pathogenesis, The Role Of APRIL & The 4-Hit Process, & A Patient Case Study

  • 

    

    Abigail Yancey, PharmD, BCPS

    Peer

  • 

    

    Kartik Kalra, MD

    Peer

• 

  RestartResume

  Expert Opinions on Characteristics of Patients With C3G at High Risk of Progression

  Medical Industry Feature

  Expert Opinions on Characteristics of Patients With C3G at High Risk of Progression

  • 

    

    Dana Rizk, MD

    Peer

  • 

    

    Carla Nester, MD

    Peer

  • 

    

    Sanjeev Sethi, MD, PhD

    Peer

  • 

    

    Leal Herlitz, MD

    Peer
• advertisement

• 

  RestartResume

  Expert Opinions on Characteristics of Patients With IgA Nephropathy (IgAN) at High Risk of Progression

  Medical Industry Feature

  Expert Opinions on Characteristics of Patients With IgA Nephropathy (IgAN) at High Risk of Progression

  • 

    

    Dana Rizk, MD

    Peer

  • 

    

    Carla Nester, MD

    Peer

  • 

    

    Sanjeev Sethi, MD, PhD

    Peer

  • 

    

    Leal Herlitz, MD

    Peer

• 

  RestartResume

  Expert Opinions on Renal Compensation and Renal Functional Reserve

  Medical Industry Feature

  Expert Opinions on Renal Compensation and Renal Functional Reserve

  • 

    

    Jai Radhakrishnan, MD

    Peer

  • 

    

    Leal Herlitz, MD

    Peer

• 

  RestartResume

  Managing Capillary Leak Syndrome: Early Recognition and Intervention in BPDCN Care

  Medical Industry Feature

  Managing Capillary Leak Syndrome: Early Recognition and Intervention in BPDCN Care

  • 

    

    Jennifer Caudle, DO, FACOFP

    Peer

  • 

    

    James McCloskey II, MD

    Peer

• 

  RestartResume

  Newborn Gene Sequencing: Expanding Early Detection of Treatable Diseases

  Medical Industry Feature

  Newborn Gene Sequencing: Expanding Early Detection of Treatable Diseases

  • 

    

    Joshua Milner, M.D.

    Peer

  • 

    

    Eric Silver, M.D.

    Peer

  • 

    

    Steven Lobritto, M.D.

    Peer
• advertisement